Govt’s cancer drug price curb likely to create Rs 3,357 crore savings estimate
New Delhi, Nov 6 (IANS) India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings…
Read More...
Read More...